Radiopharm Theranostics Limited (RADX)

Radiopharm Theranostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	34.52	29.12	18.58	11.7	26.98
Cash & Short-Term Investments	34.52	29.12	18.58	11.7	26.98
Cash Growth	-5.27%	56.75%	58.77%	-56.64%	-
Accounts Receivable	11.36	10.4	0.99	4.47	0.06
Other Current Assets	0.17	0.34	3.29	0.13	0.23
Total Current Assets	46.04	39.85	22.85	16.3	27.26
Net Property, Plant & Equipment	0.05	0.05	0.06	0.07	0
Other Intangible Assets	45.08	46.57	49.09	58.54	56.08
Other Long-Term Assets	-	-	0.04	0.04	0.04
Total Assets	91.17	86.48	72.04	74.95	83.38
Accounts Payable	10.72	9.34	10.86	5.12	2.15
Accrued Expenses	0.58	0.45	0.4	0.29	0.09
Unearned Revenue	1.02	1.72	-	-	-
Other Current Liabilities	2.99	3.42	6.32	7.82	5.63
Total Current Liabilities	15.3	14.93	17.58	13.23	7.88
Other Long-Term Liabilities	25.94	28.68	27.11	16.14	12.54
Total Long-Term Liabilities	25.94	28.68	27.11	16.14	12.54
Total Liabilities	41.23	43.61	44.68	29.37	20.42
Common Stock	209.94	176.56	100.68	97.23	86.76
Additional Paid-in Capital	0.85	0.85	0.85	2.15	-
Accumulated Other Comprehensive Income	13.37	13.12	37.93	10.36	7.11
Retained Earnings	-172.37	-145.73	-111.34	-65.35	-30.91
Total Common Shareholders' Equity	51.78	44.79	28.12	44.38	62.96
Minority Interest	-1.84	-1.92	-0.77	1.19	-
Shareholders' Equity	49.94	42.87	27.35	45.58	62.96
Total Liabilities & Equity	91.17	86.48	72.04	74.95	83.38
Net Cash (Debt)	34.52	29.12	18.58	11.7	26.98
Net Cash Growth	18.54%	56.75%	58.77%	-56.64%	-
Net Cash Per Share	3.53	4.20	14.42	11.48	44.66
Book Value	51.78	44.79	28.12	44.38	62.96
Book Value Per Share	5.30	6.46	21.83	43.54	104.22
Tangible Book Value	6.7	-1.78	-20.96	-14.16	6.89
Tangible Book Value Per Share	0.69	-0.26	-16.27	-13.89	11.40

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q